The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Epidemiology of urothelial carcinoma
Abstract
The epithelium lining is defined as the mucosal surfaces of the renal collecting tubules, calyces and pelvis, as well as the ureter, bladder and urethra. The term “urothelium” is used to refer to these surfaces. Upper tract urothelial carcinoma is a rare subset of urothelial cancers with a poor prognosis. Urinary bladder cancer is the most common malignancy involving the urinary system. Upper tract urothelial carcinoma is more common in men than in women, with a male‐to‐female ratio of 2:1. The incidence of urinary bladder cancer is also higher in men. Cigarette smoking and occupational exposure are the main upper tract urothelial carcinoma and urinary bladder cancer risk factors, while other factors are more specific to the carcinogenesis of upper tract urothelial carcinoma (i.e. Balkan endemic nephropathy, Chinese herb nephropathy). In Egypt until recent years, urinary bladder cancer was the most frequently diagnosed cancer due to Schistosoma haematobium. Substantial knowledge exists regarding the causes of upper tract urothelial carcinoma and urinary bladder cancer, and epidemiological studies have identified various chemical carcinogens that are believed to be responsible for most cases of urothelial carcinoma. In the era of precision medicine, genetic effects might play a direct role in the initiation and progression of urothelial carcinoma.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Siegel, R. L., Miller, K. D., & Jemal, A. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21332 · Cited by 16,003
Rouprêt, M., Babjuk, M., Compérat, E., Zigeuner, R., Sylvester, R. J., Burger, M., Cowan, N. C., Böhle, A., Van Rhijn, B. W. G., Kaasinen, E., et al. (2015) · European Urology · doi:10.1016/j.eururo.2015.06.044 · Cited by 1,341
Association Between Smoking and Risk of Bladder Cancer Among Men and Women
Freedman, N. D. (2011) · JAMA · doi:10.1001/jama.2011.1142 · Cited by 1,141
Urothelial Carcinoma Associated with the Use of a Chinese Herb (Aristolochia fangchi)
Nortier, J. L., Martinez, M.-C. M., Schmeiser, H. H., Arlt, V. M., Bieler, C. A., Petein, M., Depierreux, M. F., De Pauw, L., Abramowicz, D., Vereerstraeten, P., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200006083422301 · Cited by 983
UROTHELIAL CARCINOMA ASSOCIATED WITH THE USE OF A CHINESE HERB ( ARISTOLOCHIA FANGCHI )
Ortier, L. N., Arie, M., Chmeiser, H. S., Rlt, V. O. M. A., Ieler, H. A. B., Etein, M. I. P., Epierreux, M. I. F. D., Auw, L., Bramowicz, D. A. A., & Ereerstraeten, P. I. V. (2014) · Cited by 814
Aristolochic acid nephropathy: A worldwide problem
Debelle, F. D., Vanherweghem, J.-L., & Nortier, J. L. (2008) · Kidney International · doi:10.1038/ki.2008.129 · Cited by 763
Aristolochic acid and the etiology of endemic (Balkan) nephropathy
Grollman, A. P., Shibutani, S., Moriya, M., Miller, F., Wu, L., Moll, U., Suzuki, N., Fernandes, A., Rosenquist, T., Medverec, Z., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701248104 · Cited by 606
Hori, M., Matsuda, T., Shibata, A., Katanoda, K., Sobue, T., & Nishimoto, H. (2015) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyv088 · Cited by 595
Relationship between Schistosomiasis and Bladder Cancer
Mostafa, M. H., Sheweita, S. A., & O’Connor, P. J. (1999) · Clinical Microbiology Reviews · doi:10.1128/cmr.12.1.97 · Cited by 530
Cumberbatch, M. G., Rota, M., Catto, J. W. F., & La Vecchia, C. (2016) · European Urology · doi:10.1016/j.eururo.2015.06.042 · Cited by 451
Aristolochic acid-associated urothelial cancer in Taiwan
Chen, C.-H., Dickman, K. G., Moriya, M., Zavadil, J., Sidorenko, V. S., Edwards, K. L., Gnatenko, D. V., Wu, L., Turesky, R. J., Wu, X.-R., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1119920109 · Cited by 419
Raman, J. D., Messer, J., Sielatycki, J. A., & Hollenbeak, C. S. (2011) · BJU International · doi:10.1111/j.1464-410x.2010.09675.x · Cited by 364
Urothelial Carcinoma of the Bladder and the Upper Tract: Disparate Twins
Green, D. A., Rink, M., Xylinas, E., Matin, S. F., Stenzl, A., Roupret, M., Karakiewicz, P. I., Scherr, D. S., & Shariat, S. F. (2013) · Journal of Urology · doi:10.1016/j.juro.2012.05.079 · Cited by 362
Sex and racial differences in bladder cancer presentation and mortality in the US
Scosyrev, E., Noyes, K., Feng, C., & Messing, E. (2009) · Cancer · doi:10.1002/cncr.23986 · Cited by 308
Colin, P., Koenig, P., Ouzzane, A., Berthon, N., Villers, A., Biserte, J., & Rouprêt, M. (2009) · BJU International · doi:10.1111/j.1464-410x.2009.08838.x · Cited by 300
Management of extracolonic tumours in patients with Lynch syndrome
Koornstra, J. J., Mourits, M. J., Sijmons, R. H., Leliveld, A. M., Hollema, H., & Kleibeuker, J. H. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70041-5 · Cited by 212
The Epidemiology, Diagnosis, and Management of Aristolochic Acid Nephropathy: A Narrative Review
Gökmen, M. R., Cosyns, J.-P., Arlt, V. M., Stiborová, M., Phillips, D. H., Schmeiser, H. H., Simmonds, M. S. J., Cook, H. T., Vanherweghem, J.-L., Nortier, J. L., et al. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-158-6-201303190-00006 · Cited by 182
Pioglitazone and bladder cancer risk: a multipopulation pooled, cumulative exposure analysis
on behalf of the Scottish Diabetes Research Network Epidemiology Group and the Diabetes and Cancer Research Consortium, Levin, D., Bell, S., Sund, R., Hartikainen, S. A., Tuomilehto, J., Pukkala, E., Keskimäki, I., Badrick, E., Renehan, A. G., et al. (2015) · Diabetologia · doi:10.1007/s00125-014-3456-9 · Cited by 158
Rota, M., Bosetti, C., Boccia, S., Boffetta, P., & Vecchia, C. L. (2014) · Archives of Toxicology · doi:10.1007/s00204-014-1296-5 · Cited by 133
Thiazolidinediones and associated risk of bladder cancer: a systematic review and meta‐analysis
Turner, R. M., Kwok, C. S., Chen‐Turner, C., Maduakor, C. A., Singh, S., & Loke, Y. K. (2013) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12306 · Cited by 126
A meta-analysis on the association between bladder cancer and occupation
Reulen, R. C., Kellen, E., Buntinx, F., Brinkman, M. T., & Zeegers, M. P. (2008) · Scandinavian Journal of Urology and Nephrology · doi:10.1080/03008880802325192 · Cited by 125
Murta‐Nascimento, C., Silverman, D. T., Kogevinas, M., García‐Closas, M., Rothman, N., Tardón, A., García-Closas, R., Serra, C., Carrato, A., Villanueva, C. M., et al. (2007) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0743 · Cited by 102
Bladder cancer in Africa: Update
ELMAWLA, N. (2001) · Seminars in Oncology · doi:10.1016/s0093-7754(01)90089-2 · Cited by 101
Pommer, W., Bronder, E., Klimpel, A., Helmert, U., Greiser, E. M., & Molzahn, M. (1999) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/14.12.2892 · Cited by 92
Arsenic Cancer Risk Confounder in Southwest Taiwan Data Set
Lamm, S. H., Engel, A., Penn, C. A., Chen, R., & Feinleib, M. (2006) · Environmental Health Perspectives · doi:10.1289/ehp.8704 · Cited by 89
Fortuny, J., Kogevinas, M., Zens, M. S., Schned, A. R., Andrew, A. S., Heaney, J., Kelsey, K. T., & Karagas, M. R. (2007) · BMC Urology · doi:10.1186/1471-2490-7-13 · Cited by 49
Hagiwara, M., Kikuchi, E., Tanaka, N., Matsumoto, K., Ide, H., Miyajima, A., Masuda, T., Nakamura, S., & Oya, M. (2013) · The Journal of Urology · doi:10.1016/j.juro.2013.01.024 · Cited by 45
Rouissi, K., Ouerhani, S., Hamrita, B., Bougatef, K., Marrakchi, R., Chérif, M., Slama, M. R. B., Bouzouita, M., Chébil, M., & Elgaaïed, A. B. A. (2011) · Pathology & Oncology Research · doi:10.1007/s12253-011-9398-3 · Cited by 42
Molecular aspects of upper tract urothelial carcinoma
Patel, N. S., Arya, M., Muneer, A., Powles, T., Sullivan, M., Hines, J. E. W., & Kelly, J. D. (2013) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2012.10.002 · Cited by 41
Gender‐specific effect of smoking on upper tract urothelial carcinoma outcomes
Rink, M., Xylinas, E. N., Trinh, Q., Lotan, Y., Margulis, V., Raman, J. D., Fisch, M., Lee, R. K., Chun, F. K. ‐., Abdennabi, J., et al. (2013) · British Journal of Urology · doi:10.1111/bju.12014 · Cited by 39
Ehdaie, B., Furberg, H. F., Zabor, E. C., Ostroff, J. S., Shariat, S. F., Bochner, B. H., Coleman, J., & Dalbagni, G. M. (2012) · British Journal of Urology · doi:10.1111/j.1464-410x.2012.11260.x · Cited by 35
Genkinger, J. M., Vivo, I. D., Stampfer, M. J., Giovannucci, E. L., & Michaud, D. S. (2007) · International Journal of Cancer · doi:10.1002/ijc.22546 · Cited by 23
Metadata
- Authors
- Miyazaki, J., & Nishiyama, H.
- Venue
- International Journal of Urology
- Publisher
- Wiley
- Published
- 2017-05-21
- Volume
- 24
- Issue
- 10
- Pages
- 730-734
- ISSN
- 0919-8172 (ISSN-L)
- 1442-2042
- OpenAlex
- W2616936656
- Cited by
- 253
- References
- 32
- FWCI
- 16.93
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.